Gordon K. Norman, MD, MBA. Author reply by Soeren Mattke, MD, DSc
Advertisement
Articles by Gordon K. Norman, MD, MBA. Author reply by Soeren Mattke, MD, DSc
Advertisement
Latest Updated Articles
- All Things Considered, the Answer Is a Resounding Yes
Published: January 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
3
How Effective and Safe Are GLP-1s for Weight Loss?
4
Epcoritamab With Rituximab Plus Lenalidomide Approved for R/R Follicular Lymphoma in Second Line
5
